Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy

Acta Neurologica Scandinavica

Volumn 115, Issue 4, 2007, Pages 284-288

  Beydoun, S ^a   Alarcon F ^b   Mangat, S ^c   Wan, Y ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HOSPITAL EUGENIO ESPEJO   (Ecuador)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Antiepileptic drug; Neuropathies; Pain other than headache

Indexed keywords

OXCARBAZEPINE;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BACKACHE; BALANCE DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIARRHEA; DIZZINESS; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; EDEMA; ELECTROCARDIOGRAPHY MONITORING; FATIGUE; FECES COLOR; FEMALE; FOOD POISONING; GAIT DISORDER; HUMAN; HYPERTENSION; HYPONATREMIA; INNER EAR DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; MULTICENTER STUDY; NAUSEA; NEUROPATHIC PAIN; NEWBORN EXFOLIATIVE DERMATITIS; OPEN STUDY; PAIN ASSESSMENT; PAIN THRESHOLD; PATIENT ASSESSMENT; PATIENT SELECTION; PNEUMONIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN EXFOLIATION; SOMNOLENCE; STOMACH EMPTYING; STOMACH PARESIS; THERAPY EFFECT; TITRIMETRY; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; URTICARIA; VISUAL ANALOG SCALE; VITAL SIGN; VOMITING; WHEEZING;

ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 33947404698     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00710.x     Document Type: Article

References (14)

1. World Health Organization. Diabetes mellitus [WWW document]. URL http://www.who.int/mediacentre/factsheets/fs138/en/ 2002 [accessed on 7 June 2005].
2. SCHMADER KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002;18:350-4.
3. VU TN. Current pharmacologic approaches to treating neuropathic pain. Curr Pain Headache Rep 2004;8:15-8.
4. DAM M, EKBERG R, LøYNING Y, WALTIMO O, JAKOBSEN K, THE SCANDINAVIAN OXCARBAZEPINE STUDY GROUP. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989;3:70-6.
5. DOGRA S, BEYDOUN S, MAZZOLA J, HOPWOOD M, WAN Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005;9:543-54.
6. RIVIERE ME, WAN Y, HOPWOOD M, LIEBEL J. Oxcarbazepine in the treatment of painful diabetic neuropathy: a randomised, placebo-controlled study. Eur J Neurol 2004;11(Suppl. 2):101 (abs P1250).
7. BEYDOUN A, WAN Y, HOPWOOD M, LIEBEL J. Results of a randomised, placebo-controlled trial suggest oxcarbazepine has a therapeutic effect in the treatment of painful diabetic neuropathy. Eur J Neurol 2004;11(Suppl. 2):101 (abs P1251).
8. GLAUSER TA. Oxcarbazepine in the treatment of epilepsy. Pharmacotherapy 2001;21:904-19.
9. ROSENSTOCK J, TUCHMAN M, LAMOREAUX L, SHARMA U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004;110:628- 38.
10. EISENBERG E, LURIE Y, BRAKER C, DAOUD D, ISHAY A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001;57:505-9.
11. THIENEL U, NETO W, SCHWABE SK, VIJAPURKAR U, THE TOPIRAMATE DIABETIC NEUROPATHIC PAIN STUDY GROUP. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 2004;110:221-31.
12. BACKONJA M, GLANZMAN RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003;25:81-104.
13. BARCS G, WALKER EB, ELGER CE et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 2000;41:1597-607.
14. BEYDOUN A, SACHDEO RC, ROSENFELD WE et al. Oxcarbazepine monotherapy for partial-onset seizures. A multicenter, double-blind, clinical trial. Neurology 2000;54:2245-51.